Health Care & Life Sciences » Pharmaceuticals | Daito Pharmaceutical Co. Ltd.

Daito Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is June-May. All values JPY Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,869
3,373
3,426
3,885
4,263
Depreciation, Depletion & Amortization
2,445
2,440
2,643
2,818
2,853
Other Funds
663
1,256
1,135
589
1,726
Funds from Operations
4,651
4,556
4,935
6,114
5,399
Changes in Working Capital
1,907
817
1,986
1,045
66
Net Operating Cash Flow
2,745
3,739
2,949
5,070
5,465
Capital Expenditures
2,335
4,919
3,949
2,992
3,874
Sale of Fixed Assets & Businesses
1
29
-
-
69
Purchase/Sale of Investments
332
347
41
-
13
Net Investing Cash Flow
2,163
4,595
4,015
3,012
3,833
Cash Dividends Paid - Total
296
466
375
375
413
Issuance/Reduction of Debt, Net
1,769
1,498
830
1,500
1,115
Net Financing Cash Flow
2,065
503
526
1,778
1,544
Net Change in Cash
1,413
367
568
266
94
Free Cash Flow
410
1,180
1,000
2,078
1,643
Change in Capital Stock
-
2,467
71
97
1
Exchange Rate Effect
71
15
28
14
5
Other Uses
160
52
25
20
16

About Daito Pharmaceutical Co.

View Profile
Address
326 Yokamachi
Toyama Toyama 939
Japan
Employees -
Website http://www.daitonet.co.jp
Updated 07/08/2019
Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It offers drug substances, prescription and over-the-counter drugs, home-delivery medicine, and health food. The company was founded on June 30, 1942 and is headquartered in Toyama, Japan.